Dr. Roneet Lev
Dr. Roneet Lev
Episode #182 High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC
Episode #182 High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC
Episode #182 High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC
Monday 17th June 2024
Dr. Roneet Lev and experts from IASIC discuss the complex implications of rescheduling marijuana under the Controlled Substances Act.
72 minutes
Informative
Thought-provoking
Educational
Honest
Non-judgmental
About this podcast
Author:
Dr. Roneet Lev
Overview:
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Body & Mind
Links:
Visit site
Episodes:
210 (View all)
Do you want to link to this podcast?
Get the buttons here!The High Stakes of Rescheduling Marijuana
Episode Overview
- The rescheduling of marijuana could have significant public health implications.
- Changing marijuana's status under the CSA involves complex legal and medical evaluations.
- High-potency cannabis products pose potential risks that are often overlooked.
- The debate mirrors past mistakes made with opioid prescriptions.
- Scientific and medical evaluations are crucial in guiding drug policy decisions.
The harms are right in front of our eyes, but we ignore the data and follow the industry talking points just like we did in the OxyContin days
In this episode of 'High Truths on Drugs and Addiction', Dr. Roneet Lev tackles the heated topic of rescheduling marijuana under the Controlled Substances Act (CSA). With a wealth of experience as an emergency and addiction physician, Dr. Lev brings in experts from the International Academy on the Science and Impact of Cannabis (IASIC) to shed light on the complex implications of this debate. The episode features insightful discussions with Dr. Eric Voth, Dr. Libby Stout, and Dr.
Bertha Madras, who delve into the potential public health risks, the integrity of the FDA's approval process, and the broader societal impacts of changing marijuana's legal status. Dr. Lev shares personal anecdotes from her career, highlighting the parallels between the opioid crisis and the current marijuana debate. She argues that just as the medical community once fell for misleading data on opioids, it is now repeating the same mistakes with marijuana.
The conversation gets into the nitty-gritty of what rescheduling would mean for medical use, legal implications, and international treaties. The guests provide a wealth of information on the scientific and medical evaluations that underpin drug scheduling decisions. They discuss how marijuana's classification affects research opportunities and public perception. Dr. Voth and Dr. Madras offer compelling arguments against rescheduling, citing concerns about high-potency cannabis products and their potential harms.
This episode is a must-listen for anyone interested in drug policy, public health, or the ongoing debate over marijuana's legal status. Dr. Lev and her guests provide a balanced view that challenges listeners to think critically about the broader implications of rescheduling marijuana. If you're looking for a deep dive into one of today's most contentious public health issues, this episode has you covered.